Glycemic control in the critically ill: What have we learned since NICE-SUGAR?

References

• Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–67
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449–61
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125–39
   PubMed Web of Science ®Google Scholar
• Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738–48
   PubMed Web of Science ®Google Scholar
• Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190–7
   PubMed Web of Science ®Google Scholar
• Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit? Mayo Clin Proc 2009;84:400–2
   PubMed Web of Science ®Google Scholar
• The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–97
   PubMed Web of Science ®Google Scholar
• Garber AJ, Moghissi ES, Bransome EDJr, Clark NG, Clement S, Cobin RH, et al. American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004;10:4–9
   PubMedGoogle Scholar
• Moghissi ES, Korytkowski MT, DiNardo M. American Association of Clinical Endocrinologists; American Diabetes Association. Standards of care in diabetes. Diabetes Care 2010;33:S11–61
   PubMedGoogle Scholar
• Ichai C, Preiser JC. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care 2010;14:R166
   PubMed Web of Science ®Google Scholar
• Qaseem A, Humphrey L, Chou R. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;154:260–7
   PubMed Web of Science ®Google Scholar
• Jacobi J, Bircher N, Krinsley JS, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012;40:3251–76
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471–8
   PubMed Web of Science ®Google Scholar
• Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009;373:1798–807
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35:2262–7
   PubMed Web of Science ®Google Scholar
• Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010;38:1021–9
   PubMed Web of Science ®Google Scholar
• The NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012;367:1108–18
   PubMed Web of Science ®Google Scholar
• Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010;85:217–24
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Schultz MJ, Spronk PE, Harmsen RE, van Braam Houckgeest F, van der Sluijs JP, Melot C, et al. Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care 2011;15:R173
   PubMed Web of Science ®Google Scholar
• Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244–52
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008–13
   PubMed Web of Science ®Google Scholar
• Ali NA, O’Brien JMJr, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AFJr, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008;36:2316–21
   PubMed Web of Science ®Google Scholar
• Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JMJr, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008;74:679–85
   PubMed Web of Science ®Google Scholar
• Hermanides J, Vriesendorp T, Bosman R, Zandstra D, Hoekstra J, DeVries J. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010;38:838–42
   PubMed Web of Science ®Google Scholar
• Suhaimi F, Le Compte A, Preiser JC, Shaw GM, Massion P, Radermecker R, Pretty CG, et al. What makes tight glycemic control tight? The impact of variability and nutrition in two clinical studies. J DiabSci Tech 2010;4:284–98
   PubMedGoogle Scholar
• Cueni-Villoz N, Devigili A, Delodder F, Cianferoni S, Feihl F, Rossetti AO, Eggimann P, et al. variability during therapeutic hypothermia and outcome after cardiac arrest. Crit Care Med 2011;39:2225–31
   PubMed Web of Science ®Google Scholar
• Kauffman RM, Hayes RM, Buske BD, Norris PR, Campion TR, Dortch M, Jenkins JM, et al. Increasing blood glucose variability heralds hypoglycemia in the critically ill. J Surg Res 2011;170:257–61
   PubMed Web of Science ®Google Scholar
• Meynaar IW, Eslami S, Abu-Hanna A, van der Voort P, de Lange DW, de Keizer N. Blood glucose amplitude variability as predictor formortality in surgical and medical intensive care unitpatients: a multicenter cohort study. J Crit Care 2012;27:119–24
   PubMed Web of Science ®Google Scholar
• Kang Y, Wan-Hong Y, Wang B, Chen Y. The association of mean glucose level and glucose variability with intensive care unit mortality in patients with severe acute pancreatitis. J Crit Care 2012;27:146–52
   PubMed Web of Science ®Google Scholar
• Su G, Shu-Hua M, Hong T, Li Z, Yang HX, Zheng H, Zhou Y, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diab Care 2013;36:1026–32
   PubMed Web of Science ®Google Scholar
• Farrokhi F, Chandra P, Smiley D, Pasquel FJ, Peng L, Newton CA, Umpierrez GE. Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition. Endo Prac 2014;20:46–51
   Google Scholar
• Lanspa MJ, Dickerson J, Morris AH, Orme JF, Holmen J, Hirshberg EL. Coefficient of glucose variation is independentlyassociated with mortality in critically ill patientsreceiving intravenous insulin. Crit Care 2014;18:R86
   Google Scholar
• Subramaniam B, Lerner A, Novack V, Khabbaz K, Paryente-Wiesmann M, Hess P, Talmor D. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery. AnesthAnalg 2014;118:277–87
   Google Scholar
• Mackenzie IM, Whitehouse T, Nightingale PG. The metrics of glycaemic control in critical care. Intensive Care Med 2011;37:435–43
   PubMed Web of Science ®Google Scholar
• Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dyglycemia and in-hospital mortality. Crit Care Med 2012;40:3180–8
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Meyfroidt G, Van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the 3 domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care 2012;15:151–60
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Fisher M. The diabetes paradox: diabetes is not independently associated with mortality in critical illness. Hosp Prac 2012;40:31–5
   Google Scholar
• Vincent JL, Preiser JC, Sprung CL, Moreno R, Sakr Y. Insulin-treated diabetes is not associated with increased mortality in critically ill patients. Crit Care 2010;14:R12
   PubMed Web of Science ®Google Scholar
• Graham BB, Keniston A, Gajic O, Trillo Alvarez CA, Medvedev S, Douglas IS. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med 2010;38:16–24
   PubMed Web of Science ®Google Scholar
• Siegelaar SE, Hickmann M, Hoekstra JB, et al. The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis. Crit Care 2011;15:R205
   Google Scholar
• Krinsley JS, Egi M, Kiss A, Amin DM, Schuetz P, Maurer P, et al. Diabetic status and the relationship of the 3 domains of glycemic control to mortality in critically ill patients: an international multi-center cohort study. Crit Care 2013;17:R37
   PubMed Web of Science ®Google Scholar
• Marjolein K Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, Siegelaar SE, Hermanides J, Hoekstra JB, De Vries JH. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care 2013;17:R52
   Google Scholar
• Lanspa MJ, Hirshberg EL, Phillips GD, Holmen J, Stoddard G, Orme J. Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes. Chest 2013;143:1226–34
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Glycemic control in the critically ill – 3 domains and diabetic status means one size does not fit all!. Crit Care 2013;17:131
   PubMed Web of Science ®Google Scholar
• Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011;39:105–11
   PubMed Web of Science ®Google Scholar
• Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, Raj JP, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Int Care Med 2014;40:973–80
   PubMed Web of Science ®Google Scholar
• Boyd JC, Bruns DE. Effects of measurement frequency on analytical quality required for glucose measurements in ICUs: assessments by simulation models. Clin Chem 2014;60:644–50
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Bruns DE, Boyd JC. The impact of measurement frequency on the domains of glycemic control in the critically ill: A Monte Carlo simulation. J Diab Sci Tech 2015;9:1–9
   Google Scholar
• Van Herpe T, Mesotten D, Wouters PJ, Herbots J, Voets E, Burens J, de Moor B, et al. LOGIC-Insulin algorithm-guided versus nurse-directed blood glucose control during critical illness. Diab Care 2013;36:188–94
   PubMed Web of Science ®Google Scholar
• Signal M, le Compte A, Shaw GM, Chase JG. Glycemic levels in critically ill patients: are normoglycemia and low variability associated with improved outcomes? J Diab Sci Tech 2012;6:1030–7
   PubMedGoogle Scholar
• Penning S, Chase JG, Preiser JC, Pretty CG, Signal M, Melot C, Desaive T. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial. J Crit Care 2014;29:374–9
   PubMed Web of Science ®Google Scholar
• Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Tokumaru T, Liyama T, Sugimoto T, et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diab Care 2014;37:1516–24
   PubMed Web of Science ®Google Scholar
• Omar AS, Salama A, Allam M, Elgohary Y, Mohammed S, Tuli AK, Sing R. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesth 2015;15:14
   PubMedGoogle Scholar
• Krinsley JS, Preiser JC. Time in targeted blood glucose range 70-140 mg/dL is strongly associated with survival in non-diabetic critically ill adults. Crit Care 2015;19:179
   PubMed Web of Science ®Google Scholar
• Finfer S, Wernermann J, Preiser JC, Cass T, Desaive T, Hovorka R, et al. Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care 2013;17:229
   PubMed Web of Science ®Google Scholar